Literature DB >> 6118580

Preliminary studies on the immunogenicity and amount of Escherichia coli polypeptides in biosynthetic human insulin produced by recombinant DNA technology.

R S Baker, J R Schmidtke, J W Ross, W C Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6118580     DOI： 10.1016/s0140-6736(81)90589-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Immunization procedures for E. coli proteins.

Authors:  V R Anicetti; M A Simonetti; L L Blackwood; A J Jones; A B Chen
Journal:  Appl Biochem Biotechnol       Date:  1989-11       Impact factor: 2.926

2.  Development of the National Institutes of Health Guidelines for Recombinant DNA Research.

Authors:  B Talbot
Journal:  Public Health Rep       Date:  1983 Jul-Aug       Impact factor: 2.792

Review 3.  Human insulin: much ado about one amino acid?

Authors:  G E Sonnenberg; M Berger
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

Review 4.  Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

5.  Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli.

Authors:  C A Dinarello; J V O'Connor; G LoPreste; R L Swift
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

6.  Quantitation of E. coli protein impurities in recombinant human interferon-gamma.

Authors:  A B Chen; A A Championsmith; J Blanchard; J Gorrell; B A Niepelt; M M Federici; J Formento; D V Sinicropi
Journal:  Appl Biochem Biotechnol       Date:  1992-08       Impact factor: 2.926
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.